Data on this website

This website contains clinical data published under the European Medicines Agency (EMA) policy on the publication of clinical data. The clinical data have been submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure and have been assessed by the Committee for Human Medicinal Products (CHMP).

EMA is the first regulatory authority worldwide to provide such broad access to clinical data.

For more information on the clinical data on this website, see Clinical data available.

For more information on EMA and its policy on the publication of clinical data, see the EMA corporate website.

Latest news

22/03/2017: Call for experts in anonymisation of clinical data

The European Medicines Agency (EMA) has launched a call for applications to join a technical anonymisation group (TAG) with a broad range of expertise that will help EMA to further develop best practices for the anonymisation of clinical reports.

Individuals interested in becoming members of the TAG should send their CV and the declaration of interests form to by 28/04/2017.

For more information see EMA website.

20/03/2017: Clinical data for two new medicines published

Palonosetron Accord is a generic medicine used to prevent nausea and vomiting caused by chemotherapy.

Amlodipine/Valsartan Mylan is a generic medicine used in patients who have essential hypertension (high blood pressure) that is not adequately controlled on either amlodipine or valsartan taken alone.

Latest clinical data published

Palonosetron Accord (PALONOSETRON) published 16 March 2017

Amlodipine-Valsartan Mylan (AMLODIPINE / VALSARTAN) published 16 March 2017

Empliciti (Elotuzumab) published 28 February 2017

Coagadex (Human coagulation factor X) published 28 February 2017

Cubicin (Daptomycin) published 27 February 2017

Aripiprazole Mylan (Aripiprazole) published 31 January 2017

Palonosetron Hospira (Palonosetron) published 30 January 2017

Praxbind (Idarucizumab) published 21 December 2016

Tarceva (Erlotinib) published 21 December 2016

Armisarte (Pemetrexed diacid monohydrate) published 24 November 2016